Trilogy Health Solutions announced today that Orthopedic and Sports Medicine Specialists (OSMS) will participate in their…
Year: 2021
AANA Underscores Need for Policies to Improve Competition in Healthcare in Letter to Biden Administration
In an Oct. 5 letter to President Biden, American Association of Nurse Anesthesiology (AANA) President Dina Velocci, DNP, CRNA,…
Global Pharmaceutical Analytical Testing Outsourcing Market Report 2021
The “Global Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical, Stability…
Intelivideo Announces Partnership with Matrix Fitness, Elevating the Omnichannel Workout Experience for Fitness Enthusiasts Worldwide
Intelivideo, a Video on Demand (VOD) and digital technology platform for the health and wellness industry,…
Dr. Charlie Seltzer Transforms Philadelphia’s Health and Wellness Scene With New Space and Services
Philadelphia’s top weight loss doctor—and the only physician in the country to be both board certified…
Oblique Therapeutics is excited to present the recent progress on its anti-Thioredoxin mAb program at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 – 14, Washington DC, USA
Oblique Therapeutics, a biotech focused on new medicines for severe diseases with large unmet medical needs,…
U.S. Teens and Young Adults Seek Covid-19 Vaccines, Testing, and Mandates at Rates that Rival Adults–But Rates are Defined by Political Affiliation, New Survey Finds
A new national survey of teenagers and young adults aged 13-29 finds that nearly 75% surveyed received…
Tampa General Hospital and the University of South Florida Announce Launch of People Development Institute
Tampa General Hospital and the University of South Florida (USF) Muma College of Business today announced a partnership…
Network Health Medicare Plans Earn High Quality Ratings
The Centers for Medicare and Medicaid Services (CMS) released its annual quality rankings. For the 2022…
U.S. FDA Approves Cyltezo® (adalimumab-adbm) as First Interchangeable Biosimilar with Humira®
Boehringer Ingelheim today announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License…